HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characteristics of monochorionic-diamniotic growth-retarded twins during the third trimester.

Abstract
The goal of this study was to assess the characteristics of monochorionic-diamniotic (MD) growth-retarded twin infants with twin-twin transfusion syndrome (TTTS) compared with those without TTTS during the third trimester. Retrospective analyses of the growth patterns and amniotic fluid volumes were performed on 5 MD twin pregnancies in which one or both twins showed growth retardation with TTTS, and the results weve compared with those without TTTS. Eighty-three percent of growth-retarded twin infants without TTTS in MD twin gestation showed an asymmetric growth pattern, while all TTTS cases showed a symmetric pattern (p < 0.05). Polyhydramnios of the co-twin was found in 80% of TTTS cases, while no polyhydramnios was found in patients without TTTS (p < 0.05). Assessment of growth patterns and amniotic fluid volume may be useful to exclude the possibility of TTTS in MD growth-retarded twin pregnancies during the third trimester.
AuthorsS Suzuki, S Okudaira, R Sawa, Y Yoneyama, H Asakura, S Shin, K Kaneko, T Araki
JournalNihon Ika Daigaku zasshi (Nihon Ika Daigaku Zasshi) Vol. 66 Issue 5 Pg. 300-4 (Oct 1999) ISSN: 0048-0444 [Print] Japan
PMID10547994 (Publication Type: Journal Article, Twin Study)
Topics
  • Adult
  • Amnion (diagnostic imaging)
  • Amniotic Fluid
  • Chorion (diagnostic imaging)
  • Female
  • Fetal Growth Retardation (complications, diagnostic imaging)
  • Fetofetal Transfusion (complications, diagnosis)
  • Humans
  • Pregnancy
  • Pregnancy Trimester, Third
  • Pregnancy, Multiple
  • Retrospective Studies
  • Ultrasonography, Prenatal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: